Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 5,927.00
+50.00 (0.85%)
Apr 16, 2026, 3:30 PM JST
Kobayashi Pharmaceutical Market Cap
Kobayashi Pharmaceutical has a market cap or net worth of 436.89 billion as of April 16, 2026. Its market cap has increased by 1.15% in one year.
Market Cap
436.89B
Enterprise Value
366.96B
Revenue
165.74B
Ranking
n/a
PE Ratio
119.50
Stock Price
5,927.00
Market Cap Chart
Since August 17, 1999, Kobayashi Pharmaceutical's market cap has increased from 245.70B to 436.89B, an increase of 77.81%. That is a compound annual growth rate of 2.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 436.89B | 8.27% |
| Dec 30, 2025 | 403.51B | -12.87% |
| Dec 30, 2024 | 463.13B | -8.08% |
| Dec 29, 2023 | 503.84B | -22.52% |
| Dec 30, 2022 | 650.29B | -7.68% |
| Dec 30, 2021 | 704.43B | -28.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.68T |
| Shiseido Company | 1.29T |
| Rohto Pharmaceutical | 550.56B |
| Lion Corporation | 446.93B |
| KOSE Holdings | 334.39B |
| Pola Orbis Holdings | 289.55B |
| Paltac | 286.77B |
| MTG Co., Ltd. | 251.32B |